VOR

Vor Biopharma Inc. - Common Stock (VOR)

About Vor Biopharma Inc. - Common Stock (VOR)

Vor Biopharma, Inc. is a clinical-stage biotechnology company transforming the treatment of autoimmune diseases. It is focused on rapidly advancing telitacicept, a novel dual-target fusion protein, through Phase 3 clinical development and potential commercialization to address serious autoantibody-driven conditions worldwide. The company was founded by Aleks Radovic-Moreno and Siddhartha Mukherjee on December 30, 2015 and is headquartered in Boston, MA.

Details

Daily high

$22.13

Daily low

$21.48

Price at open

$21.82

52 Week High

$49.95

52 Week Low

$6.50

Market cap

1.3B

Dividend yield

Volume

958,834

Avg. volume

951,661

P/E ratio

-.26

Vor Biopharma Inc. - Common Stock News